Viewing StudyNCT05717166



Ignite Creation Date: 2024-05-06 @ 6:34 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05717166
Status: RECRUITING
Last Update Posted: 2023-10-12
First Post: 2023-01-26

Brief Title: A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor
Sponsor:
Organization: Lawson Health Research Institute

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 180
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: